1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Myelofibrosis Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Type
6.1 Hydroxyurea
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Immunomodulators
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 JAK Inhibitor
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Treatment Type
7.1 Blood Transfusion
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Chemotherapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Androgen Therapy
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Stem Cell/Bone Marrow Transplantation
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Bone Marrow Transplant Centres
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AllCells LLC
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 American Type Culture Collection Inc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Amgen Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bristol-Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Eli Lilly and Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 Gilead Sciences Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Incyte Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Merck & Co. Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Novartis AG
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Myelofibrosis Treatment Market: Major Drivers and Challenges
Figure 2: Global: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Myelofibrosis Treatment Market: Breakup by Drug Type (in %), 2023
Figure 5: Global: Myelofibrosis Treatment Market: Breakup by Treatment Type (in %), 2023
Figure 6: Global: Myelofibrosis Treatment Market: Breakup by End User (in %), 2023
Figure 7: Global: Myelofibrosis Treatment Market: Breakup by Region (in %), 2023
Figure 8: Global: Myelofibrosis Treatment (Hydroxyurea) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Myelofibrosis Treatment (Hydroxyurea) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Myelofibrosis Treatment (Immunomodulators) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Myelofibrosis Treatment (Immunomodulators) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Myelofibrosis Treatment (JAK Inhibitor) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Myelofibrosis Treatment (JAK Inhibitor) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Myelofibrosis Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Myelofibrosis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Myelofibrosis Treatment (Blood Transfusion) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Myelofibrosis Treatment (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Myelofibrosis Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Myelofibrosis Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Myelofibrosis Treatment (Androgen Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Myelofibrosis Treatment (Androgen Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Myelofibrosis Treatment (Stem Cell/Bone Marrow Transplantation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Myelofibrosis Treatment (Stem Cell/Bone Marrow Transplantation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Myelofibrosis Treatment (Other Treatment Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Myelofibrosis Treatment (Other Treatment Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Myelofibrosis Treatment (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Myelofibrosis Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Myelofibrosis Treatment (Bone Marrow Transplant Centres) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Myelofibrosis Treatment (Bone Marrow Transplant Centres) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Myelofibrosis Treatment (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Myelofibrosis Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: North America: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: North America: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: United States: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: United States: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Canada: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Canada: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Asia-Pacific: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Asia-Pacific: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: China: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: China: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Japan: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Japan: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: India: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: India: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: South Korea: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: South Korea: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Australia: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Australia: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Indonesia: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Indonesia: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Others: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Others: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Europe: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Europe: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Germany: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Germany: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: France: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: France: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: United Kingdom: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: United Kingdom: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Italy: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Italy: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Spain: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Spain: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Russia: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Russia: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Latin America: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Latin America: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Brazil: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Brazil: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Mexico: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Mexico: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Middle East and Africa: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Middle East and Africa: Myelofibrosis Treatment Market: Breakup by Country (in %), 2023
Figure 80: Middle East and Africa: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Global: Myelofibrosis Treatment Industry: SWOT Analysis
Figure 82: Global: Myelofibrosis Treatment Industry: Value Chain Analysis
Figure 83: Global: Myelofibrosis Treatment Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Myelofibrosis Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Myelofibrosis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 3: Global: Myelofibrosis Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
Table 4: Global: Myelofibrosis Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Myelofibrosis Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Myelofibrosis Treatment Market: Competitive Structure
Table 7: Global: Myelofibrosis Treatment Market: Key Players